Chronic Dosing Cross-Over Study to Assess the Efficacy and Safety of Glycopyrronium (PT001) in Adult Subjects With Intermittent Asthma or Mild to Moderate Persistent Asthma

Pearl Therapeutics Inc., Cornelius

Pearl Therapeutics Inc., Gastonia

Pearl Therapeutics Inc., Raleigh

Pearl Therapeutics Inc., Monroe

Pearl Therapeutics Inc., Shelby

Pearl Therapeutics Inc., Asheville

Pearl Therapeutics Inc., Columbia

Pearl Therapeutics Inc., Ormond Beach

Pearl Therapeutics Inc., Miami

Pearl Therapeutics Inc., Miami

Pearl Therapeutics Inc., Kissimmee

Pearl Therapeutics Inc., Birmingham

Pearl Therapeutics Inc., Grove City

Pearl Therapeutics Inc., Middleburg Heights

Pearl Therapeutics Inc., Iowa City

Pearl Therapeutics Inc., Evanston

Pearl Therapeutics Inc., St Louis

Pearl Therapeutics Inc., Omaha

Pearl Therapeutics Inc., McKinney

Pearl Therapeutics Inc., Dallas

Pearl Therapeutics Inc., Killeen

Pearl Therapeutics Inc., Waco

Pearl Therapeutics Inc., New Braunfels

Pearl Therapeutics Inc., San Antonio

Pearl Therapeutics Inc., El Paso

Pearl Therapeutics Inc., Colorado Springs

Pearl Therapeutics Inc., Los Angeles

Pearl Therapeutics Inc., Los Angeles

Pearl Therapeutics Inc., Los Angeles

Pearl Therapeutics Inc., Quartz Hill

Pearl Therapeutics Inc., Los Angeles

Pearl Therapeutics Inc., Rolling Hills Estates

Pearl Therapeutics Inc., Cerritos

Pearl Therapeutics Inc., Rancho Mirage

Pearl Therapeutics Inc., Anaheim

Pearl Therapeutics Inc., Bakersfield

Pearl Therapeutics Inc., Stockton

Pearl Therapeutics Inc., Lake Oswego

Pearl Therapeutics Inc., Medford

Pearl Therapeutics Inc., Fall River

Pearl Therapeutics Inc., North Dartmouth

Pearl Therapeutics Inc., Skillman

Pearl Therapeutics Inc., Verona